Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Ebselen by Sound Pharmaceuticals for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Ebselen is under clinical development by Sound Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19). According to...
Ebselen by Sound Pharmaceuticals for Meniere Disease: Likelihood of Approval
Ebselen is under clinical development by Sound Pharmaceuticals and currently in Phase III for Meniere Disease. According to GlobalData, Phase...
Ebselen by Sound Pharmaceuticals for Drug Toxicity: Likelihood of Approval
Ebselen is under clinical development by Sound Pharmaceuticals and currently in Phase II for Drug Toxicity. According to GlobalData, Phase...